Like CD73, CD39 is expressed on both infiltrating immune cells, as well as on cancer cells themselves in a range of human cancers, including lung cancer, melanoma, pancreatic cancer and lymphoma [66–68], and studies have correlated high CD39 expression with unfavorable outcomes (Table 1) [69–71]. The gene discussed is NT5E; the disease is lung cancer.